• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东亚静脉血栓栓塞人群中的先天性血栓形成倾向:一项系统评价和荟萃分析。

Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis.

作者信息

Zhu Xi-Jie, Liu Zi-Yi, Wang Pei-Wen, Wang Jia, Wen Shi-Di, Zhang Jie-Xin, Zhu Yong-Jian, Sun Ming-Li, Xu Xi-Qi, Sun Kai, Lian Tian-Yu, Cheng Chun-Yan, Jing Zhi-Cheng

机构信息

Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Perinatal Institute and Section of Neonatology, Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

出版信息

Res Pract Thromb Haemost. 2023 Aug 2;7(6):102157. doi: 10.1016/j.rpth.2023.102157. eCollection 2023 Aug.

DOI:10.1016/j.rpth.2023.102157
PMID:37674867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10477689/
Abstract

BACKGROUND

Various inherited traits contribute to the overall risk of venous thromboembolism (VTE). In addition, the epidemiology of thrombophilia in the East-Asian VTE population remains unclear; thus, we aimed to assess the proportion of hereditary thrombophilia via a meta-analysis.

METHODS

Publications from PubMed, EMBASE, web of science, and Cochrane before December 30, 2022, were searched. Studies from Japan, Korea, China, Hong Kong, Taiwan, Singapore, Thailand, Vietnam, Myanmar, and Cambodia were included. Congenital thrombophilia was described as diseases including protein C (PC) deficiency, protein S (PS) deficiency, antithrombin (AT) deficiency, factor (F)V Leiden (FVL), and prothrombin G20210A mutations. Studies were selected by 2 reviewers for methodological quality analysis. A random-effects model was used for the meta-analysis, assuming that estimated effects in the different studies are not identical.

RESULTS

Forty-four studies involving 6453 patients from 7 counties/regions were included in the meta-analysis. The prevalence of PC, PS, and AT deficiencies were 7.1%, 8.3%, and 3.8%, respectively. Among 2924 patients from 22 studies, 5 patients were carriers of FVL mutation. Among 2196 patients from 10 studies, 2 patients were carriers of prothrombin G20210A mutation in a Thailand study.

CONCLUSION

The prevalence of PC, PS, and AT deficiencies was relatively high, while a much lower prevalence of FVL and prothrombin G20210A mutations were identified in East-Asian patients with VTE. Our data stress the relative higher prevalence of PC, PS, and AT deficiencies for thrombophilia in the East-Asian VTE population.

摘要

背景

多种遗传特征会影响静脉血栓栓塞症(VTE)的总体风险。此外,东亚VTE人群中血栓形成倾向的流行病学情况仍不明确;因此,我们旨在通过荟萃分析评估遗传性血栓形成倾向的比例。

方法

检索了2022年12月30日前发表于PubMed、EMBASE、科学网和Cochrane的文献。纳入了来自日本、韩国、中国、中国香港、中国台湾、新加坡、泰国、越南、缅甸和柬埔寨的研究。先天性血栓形成倾向被描述为包括蛋白C(PC)缺乏症、蛋白S(PS)缺乏症、抗凝血酶(AT)缺乏症、因子(F)V Leiden(FVL)和凝血酶原G20210A突变等疾病。由两名评审员选择研究进行方法学质量分析。采用随机效应模型进行荟萃分析,假设不同研究中的估计效应不相同。

结果

荟萃分析纳入了涉及7个国家/地区6453例患者的44项研究。PC、PS和AT缺乏症的患病率分别为7.1%、8.3%和3.8%。在22项研究的2924例患者中,有5例为FVL突变携带者。在10项研究的2196例患者中,泰国一项研究中有2例为凝血酶原G20210A突变携带者。

结论

PC、PS和AT缺乏症的患病率相对较高,而在东亚VTE患者中,FVL和凝血酶原G20210A突变的患病率要低得多。我们的数据强调了在东亚VTE人群中,PC、PS和AT缺乏症在血栓形成倾向方面的相对较高患病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/487617a7cc94/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/b536881dc5a3/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/cb1d7b47437a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/a2f4624e83b8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/772313899180/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/611ca21063a9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/c4f56f97a1ad/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/487617a7cc94/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/b536881dc5a3/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/cb1d7b47437a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/a2f4624e83b8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/772313899180/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/611ca21063a9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/c4f56f97a1ad/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d25b/10477689/487617a7cc94/gr6.jpg

相似文献

1
Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis.东亚静脉血栓栓塞人群中的先天性血栓形成倾向:一项系统评价和荟萃分析。
Res Pract Thromb Haemost. 2023 Aug 2;7(6):102157. doi: 10.1016/j.rpth.2023.102157. eCollection 2023 Aug.
2
Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.口服避孕药、血栓形成倾向与静脉血栓栓塞风险:系统评价和荟萃分析。
J Thromb Haemost. 2016 Jul;14(7):1393-403. doi: 10.1111/jth.13349. Epub 2016 Jun 16.
3
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.高风险情况下的易栓症筛查:系统评价与成本效益分析。易栓症筛查的血栓形成:风险与经济评估(TREATS)研究。
Health Technol Assess. 2006 Apr;10(11):1-110. doi: 10.3310/hta10110.
4
Venous thromboembolism risk in adults with hereditary thrombophilia: a systematic review and meta-analysis.遗传性血栓形成倾向成年人静脉血栓栓塞风险:系统评价和荟萃分析。
Ann Hematol. 2024 Oct;103(10):4285-4294. doi: 10.1007/s00277-024-05926-2. Epub 2024 Aug 21.
5
Risk Factors of Venous Thromboembolism in Sudanese Pregnant Women.苏丹孕妇静脉血栓栓塞的风险因素
Balkan J Med Genet. 2022 Jun 5;24(2):49-54. doi: 10.2478/bjmg-2021-0018. eCollection 2021 Nov.
6
Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis.妊娠、血栓形成倾向与首次静脉血栓形成风险:系统评价与贝叶斯荟萃分析
BMJ. 2017 Oct 26;359:j4452. doi: 10.1136/bmj.j4452.
7
Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.阿尔及利亚东部人群静脉血栓栓塞的遗传风险因素
Clin Appl Thromb Hemost. 2017 Mar;23(2):105-115. doi: 10.1177/1076029615600789. Epub 2016 Jul 10.
8
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.凝血因子V Leiden或凝血酶原G20210A突变杂合子携带者复发性静脉血栓栓塞的风险。前瞻性研究的系统评价。
Haematologica. 2007 Aug;92(8):1107-14. doi: 10.3324/haematol.10234.
9
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.凝血因子V莱顿突变和凝血酶原G20210A突变在成年静脉血栓栓塞症患者及其携带突变的家庭成员中的预测价值:一项系统评价
JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853.
10
Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis.遗传性血栓形成倾向与复发性妊娠丢失:系统评价和荟萃分析。
Hum Reprod. 2021 Apr 20;36(5):1213-1229. doi: 10.1093/humrep/deab010.

引用本文的文献

1
Comparison of natural anticoagulant deficiency in cerebral venous thrombosis with deep venous thrombosis.脑静脉血栓形成与深静脉血栓形成中天然抗凝剂缺乏的比较。
Med Int (Lond). 2025 Feb 5;5(2):19. doi: 10.3892/mi.2025.218. eCollection 2025 Mar-Apr.
2
Efficacy and Safety of Direct Oral Anticoagulants After Mechanical Thrombectomy in Venous Thromboembolism: A Comparative Study of 55 Patients.直接口服抗凝剂在静脉血栓栓塞症机械取栓后的疗效和安全性:55 例患者的比较研究。
Med Sci Monit. 2024 Nov 25;30:e946362. doi: 10.12659/MSM.946362.
3
Genetic factors, risk prediction and AI application of thrombotic diseases.

本文引用的文献

1
Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压中先天性血栓形成倾向的患病率、遗传背景及临床表型
JACC Asia. 2022 May 17;2(3):247-255. doi: 10.1016/j.jacasi.2022.02.010. eCollection 2022 Jun.
2
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.VTE疾病的抗栓治疗:CHEST指南及专家小组报告的第二次更新
Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 2.
3
Clinical Impact of Heritable Thrombophilia on Neonatal-Onset Thromboembolism: A Nationwide Study in Japan.
血栓性疾病的遗传因素、风险预测及人工智能应用
Exp Hematol Oncol. 2024 Aug 27;13(1):89. doi: 10.1186/s40164-024-00555-x.
4
Genetic risk stratification of inflammatory bowel disease-associated venous thromboembolism: An Asian perspective.炎症性肠病相关静脉血栓栓塞的遗传风险分层:亚洲视角。
World J Gastroenterol. 2024 Mar 7;30(9):1250-1252. doi: 10.3748/wjg.v30.i9.1250.
5
Safety and efficacy of extended thrombophilia screening directed venous thromboembolic events (VTE) prophylaxis in live liver donors: do we really need extended thrombophilia screening routinely?扩大血栓形成倾向筛查对活体肝供者预防静脉血栓栓塞事件(VTE)的安全性和有效性:我们真的需要常规进行扩大血栓形成倾向筛查吗?
Ann Med Surg (Lond). 2024 Jan 30;86(3):1297-1303. doi: 10.1097/MS9.0000000000001772. eCollection 2024 Mar.
遗传性血栓形成倾向对新生儿期起病的血栓栓塞症的临床影响:日本的一项全国性研究。
J Pediatr. 2021 Nov;238:259-267.e2. doi: 10.1016/j.jpeds.2021.07.001. Epub 2021 Jul 8.
4
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
5
Association between congenital thrombophilia and outcomes in pulmonary embolism patients.先天性血栓形成倾向与肺栓塞患者预后之间的关联。
Blood Adv. 2020 Dec 8;4(23):5958-5965. doi: 10.1182/bloodadvances.2020002955.
6
[Screening for inherited thrombophilia and genome sequencing].[遗传性血栓形成倾向筛查与基因组测序]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018 Dec 25;47(6):606-611. doi: 10.3785/j.issn.1008-9292.2018.12.07.
7
Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer.泰国非癌症患者静脉血栓栓塞(VTE)复发的危险因素。
Hematology. 2019 Dec;24(1):159-165. doi: 10.1080/10245332.2018.1535535. Epub 2018 Oct 18.
8
The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms.遗传性血栓形成倾向在韩国无诱因静脉血栓栓塞症患者中的流行率和临床表现。
PLoS One. 2017 Oct 17;12(10):e0185785. doi: 10.1371/journal.pone.0185785. eCollection 2017.
9
Thrombophilia Testing and Venous Thrombosis.血栓形成倾向检测与静脉血栓形成
N Engl J Med. 2017 Sep 21;377(12):1177-1187. doi: 10.1056/NEJMra1700365.
10
[Correlation of Thrombosis and Prothrombotic State with Coagulation Factor V Gene Polymorphism and APCR. HHcy].血栓形成及血栓前状态与凝血因子V基因多态性及活化蛋白C抵抗的相关性。高同型半胱氨酸血症
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Dec;24(6):1850-1855. doi: 10.7534/j.issn.1009-2137.2016.06.043.